Press Releases
(click on the titles to see the full text)
-
Functional Profiling Offers New Platform for Cancer Drug Discovery and Therapeutics
Ex-Vivo Analysis Recreates Human Tumor Cell Microenvironment and (April 12, 2008)
-
Targeted Cancer Therapy Improved with Ex-Vivo Chemosensitivity
Researchers at Rational Therapeutics (Long Beach, Calif.) www.rationaltherapeutics.com have reported clinical results obtained with a laboratory technique (Ex-Vivo Analysis of Programmed Cell Death - EVA-PCD(TM)) that accurately identifies patients who are candidates for targeted cancer therapy. (June 1, 2007)
-
Angels Foundation Donates $10,000 to Nagourney Cancer Institute
Sue Allen, lung cancer survivor, joins Dr. Robert Nagourney at Angels Stadium to accept a $10,000 donation from the Angels Baseball Foundation. (May 30, 2007)
-
Chemotherapy Experts Refute ASCO Recommendations on Use of Drug Sensitivity and Resistance Assays; Flawed Analytic Methods and Conflicts of Interest Cited as Factors Behind ASCO Panel Findings
Business Wire. (September 1, 2004)
-
Laboratory-Assay Identifies Topotecan as Promising Therapy for Recurrent Breast Cancer.
British Journal of Cancer Reports Novel Finding for Drug Typically Used to Treat Lung and Ovarian Cancers. November 2003. (November 3, 2003)
-
Pretreated Ovarian Cancer Patients Respond To Gemcitabine, Cisplatin
(June 1, 2003)
-
Robert Nagourney, MD Named Medical Director of Malcolm C. Todd, M.D. Cancer Institute at Long Beach Memorial Medical Center and Miller Children’s Hospital.
(May 1, 2003)
-
Studies Report Dramatic Improvement in Cancer Patient Outcomes Using Treatment Developed by Ex-Vivo Chemosensitivity Analysis.
Phase II Studies in Leading Medical Journal Confirm Effectiveness of Novel Ex-Vivo Assay- Based Drug Combination for Patients with Relapsed Ovarian Cancer. (January 13, 2003)
-
Chemical Analysis Confirms PC-SPES Contains DES, Indomethacin and Warfarin; Results Presented at AACR Late Breaking Session.
Researchers in USA and Czech Republic Identify Synthetic Prescription Compounds in Popular Herbal Treatment for Prostate Cancer. (April 9, 2002)
-
Chemical Analysis Confirms PC-SPES Contains DES, Indomethacin and Warfarin; Results Presented at AACR Late Breaking Session
Researchers in USA and Czech Republic Identify Synthetic Prescription Compounds in Popular Herbal Treatment for Prostate Cancer (April 9, 2002)
-
Laboratory-Directed Treatment Improves Response and Survival for Patients with Recurrent Ovarian Cancer
(May 20, 2000)
-
Arsenic Trioxide Offers Promising Treatment for Breast, Lung, Ovarian and Other Cancers
Unexpected Study Results to be Unveiled at AACR Annual Meeting (April 12, 1999)
-
Gemcitabine-Cisplatin: Powerful Drug Combination Found Effective Against Ovarian, Breast and Other Cancers
Drug Combination's Effectiveness in Treating a Range of Cancers Discovered Via Breakthrough Chemosensitivity Test (May 18, 1998)
-
Gemcitabine / Cisplatin Drug Combination Offers Promising Treatment for a Variety of Cancer Patients
Study to be Unveiled at Leading Cancer Research Conference (March 28, 1998)
-
Ex-Vivo Apoptotic (EVA-PCD™) Assay Confirms Efficacy of Chemosensitivity Testing
(May 15, 1997)
-
Cancer Patients Flock To So. Cal. Center For Breakthrough Treatment
ABC News Feature Attracts Patients From Around The Nation (September 16, 1996)